PRIA Logo™
KansasHB 23652025–2026 Regular SessionHouse

Adding and removing certain substances in schedules I, III and IV of the uniform controlled substances act and making conforming changes to the criminal code definition of fentanyl-related controlled substances.

Sponsored By: Sponsor information unavailable

Signed by Governor

public health and welfarehealth and human services

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

5 provisions identified: 1 benefits, 3 costs, 1 mixed.

Broader rules for drug analogs and fentanyl

The law broadens what counts as a controlled substance analog. A substance can be an analog if it has a similar structure, similar effects, or is sold as having similar effects. It also expands the list of fentanyl‑related substances to include many named chemicals and their analogs. FDA‑approved drugs and some covered research drugs are not treated as analogs. People who make, sell, or possess these substances face fentanyl‑related or analog charges.

More substances banned in Schedule I

The law adds certain opiates and fentanyl analogs to Schedule I. Making, selling, or possessing these is illegal under state law. The listing covers related isomers, salts, and similar forms. Research and handling rules for Schedule I now apply to these chemicals.

New lists for Schedules III and IV medicines

The law updates what sits in Schedules III and IV. Ketamine and approved GHB drug products are in Schedule III. Many benzodiazepines, sleep aids, and some stimulants are in Schedule IV. Doctors and pharmacies must follow Schedule III and IV prescription and dispensing rules. Some narcotic mixtures stay in Schedule III only at low doses (for example, codeine not more than 1.8 g per 100 mL or 90 mg per pill). Phentermine stays in Schedule IV unless and until federal law removes it. The state board can exempt some low‑abuse mixtures by rule. Old sections are repealed so these new lists control.

Fentanyl test strips not paraphernalia

The law says testing materials for fentanyl, fentanyl analogs, ketamine, and GHB are not drug paraphernalia. You can carry or use these test kits without that alone being a crime. This supports safer drug testing and harm reduction.

Five-plant rule for drug cultivation

The law defines “cultivate” as planting or helping grow five or more plants that can produce controlled drugs. Growing five or more counts as cultivation under Kansas law. This makes it clearer when charges can apply.

Sponsors & Cosponsors

Sponsors

There is no primary sponsor on record.

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 271 • No: 56

House vote • 4/23/2026

Yea: 76 Nay: 49

Yes: 76 • No: 49

House vote • 4/23/2026

Yea: 34 Nay: 5

Yes: 34 • No: 5

House vote • 4/23/2026

Yea: 121 Nay: 2

Yes: 121 • No: 2

House vote • 4/23/2026

Yea: 40 Nay: 0

Yes: 40 • No: 0

Actions Timeline

  1. Approved by Governor on Friday, April 10, 2026

    4/10/2026House

  2. Reengrossed on Sunday, March 29, 2026

    4/9/2026House

  3. Enrolled and presented to Governor on Friday, April 3, 2026

    4/9/2026House

  4. Conference Committee Report was adopted; Yea: 76 Nay: 49

    3/27/2026House

  5. Conference committee report now available

    3/26/2026Senate

  6. Conference Committee Report was adopted; Yea: 34 Nay: 5

    3/26/2026Senate

  7. Conference committee report now available

    3/26/2026House

  8. Conference committee report now available

    3/26/2026Senate

  9. Conference committee report now available

    3/25/2026Senate

  10. Conference Committee Report agree to disagree adopted; Senator Gossage, Senator Clifford and Senator Holscher appointed as second conferees

    3/25/2026Senate

  11. Conference Committee Report agree to disagree adopted; Representative Carpenter, W., Representative Bryce and Representative Ruiz, S. appointed as second conferees

    3/25/2026House

  12. Nonconcurred with amendments; Conference Committee requested; appointed Representative Carpenter, W. , Representative Bryce and Representative Ruiz, S. as conferees

    3/20/2025House

  13. Motion to accede adopted; Senator Gossage, Senator Clifford and Senator Holscher appointed as conferees

    3/20/2025Senate

  14. Committee of the Whole - Committee Report be adopted

    3/19/2025Senate

  15. Committee of the Whole - Be passed as amended

    3/19/2025Senate

  16. Emergency Final Action - Passed as amended; Yea: 40 Nay: 0

    3/19/2025Senate

  17. Committee Report recommending bill be passed as amended by Committee on Public Health and Welfare

    3/17/2025Senate

  18. Hearing: Wednesday, March 12, 2025, 8:30 AM Room 142-S

    3/12/2025Senate

  19. Referred to Committee on Public Health and Welfare

    2/26/2025Senate

  20. Engrossed on Monday, February 24, 2025

    2/26/2025House

  21. Received and Introduced

    2/25/2025Senate

  22. Final Action - Passed as amended; Yea: 121 Nay: 2

    2/20/2025House

  23. Committee of the Whole - Committee Report be adopted

    2/19/2025House

  24. Committee of the Whole - Motion to Amend - Offered by Representative Sutton

    2/19/2025House

  25. Committee of the Whole - Amendment by Representative Sutton was rejected

    2/19/2025House

Bill Text

  • As Amended by House Committee

    PDF

  • As Amended by Senate Committee

    PDF

  • As introduced

    PDF

  • Enrolled

    PDF

Related Bills

Back to State Legislation